You are here: Industry Insights > drug

News List

Lilly reports positive data for breast cancer drug pharmatimes
April 26, 2017
Eli Lilly is gearing up to file data for its experimental breast cancer drug abemaciclib after it was found to slow disease progression in a late-stage trial.
Valeant Pharmaceuticals lists price of plaque psoriasis drug at $3,500 per month pharmaceutical-technology
April 25, 2017
Valeant Pharmaceuticals International has decided to set the price of its biologic psoriasis treatment, known as...
Psoriasis drug Siliq will be cheapest in class, Valeant reveals pharmafile
April 25, 2017
Canadian pharmaceutical firm Valeant has announced the list price for its psoriasis treat Siliq (brodalumab) will stand at $3,500 a month, in an effort to undercut its rivals in the space.
BMS presents promising data for NASH drug pharmatimes
April 25, 2017
Bristol-Myers Squibb’s investigational liver disease candidate has hit its targets in a mid-stage trial, supporting further research...
Investigational ImmunoGen drug gives hope against platinum-resistant ovarian cancer pharmafile
April 21, 2017
Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective...
FDA grants Breakthrough Therapy designation to Novartis CTL019 for DLBCL pharmaceutical-technology
April 20, 2017
Novartis’ investigational chimeric antigen receptor T-cell (CAR-T) therapy, CTL019, has received Breakthrough Therapy ...
SMC u-turn backs Roche’s Kadcyla for breast cancer pharmatimes
April 12, 2017
Women in Scotland will be among the first in the UK to have routine NHS access to Roche’s breast cancer drug Kadcyla ...
Final NICE no for Shire’s pancreatic cancer drug pharmatimes
March 29, 2017
Pancreatic cancer patients will not be able to get routine access to Shire’s Onivyde on the National Health Service following a final rejection from cost regulators.
Novartis’ heart drug serelaxin fails in key trial pharmatimes
March 23, 2017
Novartis is considering the future of serelaxin after the drug hit another setback failing to meet key goals in a late-stage...
Verona signs up QuintilesIMS for respiratory drug development pharmatimes
March 23, 2017
London, UK-based clinical biopharma Verona Pharma has entered into a global strategic services agreement with...

Previous page 1 2 3 Next page